Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Editorial Board125
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity107
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer93
Exploiting antifungal immunity in the clinical context79
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells72
Aging of lymphoid stromal architecture impacts immune responses66
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity54
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi54
Editorial Board50
Microbial metabolites and immunotherapy: Basic rationale and clinical indications49
Resolving inflammatory links between myocardial infarction and vascular dementia48
Pyroptosis modulation by bacterial effector proteins47
Immunity to pathogenic fungi in the eye37
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity37
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?37
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)37
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity36
Pyroptosis: A road to next-generation cancer immunotherapy36
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease35
Pyroptosis and the cellular consequences of gasdermin pores35
The noncanonical inflammasome-induced pyroptosis and septic shock34
Western diet influences on microbiome and carcinogenesis33
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment31
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets31
Introduction to the special issue: Neutrophils in the tumor microenvironment31
Introduction to the Special Issue: Nanoparticles and immune responses30
Immunity to fungi: Editorial overview30
Specialized pro-resolving mediators as modulators of immune responses29
The evolving biology of cross-presentation28
Adaptive NK cell response to human cytomegalovirus: Facts and open issues27
Cellular and molecular diversity in spondyloarthritis27
The paradox of aging: Aging-related shifts in T cell function and metabolism27
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases26
TREM2: A new player in the tumor microenvironment26
Recent developments in C3-targeted complement therapeutics24
The dual role of neutrophils in cancer23
Sialic acid and Siglec receptors in tumor immunity and immunotherapy23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy23
Antigen discovery for the development of cancer immunotherapy23
Introduction to the Special Issue: Nutrition, microbiota and immunity22
Thymus aging and immune reconstitution, progresses and challenges22
T cell control of SARS-CoV-2: When, which, and where?21
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases21
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming20
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
Introduction to the special issue: Complexity and diversity of immune responses in COVID-1919
Targeting the tissue-complosome for curbing inflammatory disease19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity18
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells17
Publisher's note: Welcome Prof. Guido Kroemer17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice17
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease17
T cell fate decisions during memory cell generation with aging17
Natural killer cell responses to human oncogenic γ-herpesvirus infections16
Promotion of trained innate immunity by nanoparticles16
Proteostasis in T cell aging16
Better safe than sorry: Naive T-cell dynamics in healthy ageing16
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy16
Identification of T cell antigens in the 21st century, as difficult as ever15
Editorial Board15
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis15
Cellular and molecular heterogeneity in systemic lupus erythematosus15
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions15
The complement system in clinical oncology: Applications, limitations and challenges15
A major mechanism for immunomodulation: Dietary fibres and acid metabolites14
The multisensory regulation of unconventional T cell homeostasis14
Human thymus in health and disease: Recent advances in diagnosis and biology14
Epigenetic and transcriptional control of gasdermins14
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging14
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review14
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation13
The gut-enthesis axis and the pathogenesis of Spondyloarthritis13
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics13
Emerging opportunities for C3 inhibition in the eye13
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]13
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond12
Durability of immune responses to SARS-CoV-2 infection and vaccination12
Impact of cancer cell-intrinsic features on neutrophil behavior12
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases12
Microbial gasdermins: More than a billion years of pyroptotic-like cell death12
Siglecs as modulators of macrophage phenotype and function12
Unconventional protein secretion by gasdermin pores12
Systems analysis of innate and adaptive immunity in Long COVID12
Pyroptosis-induced inflammation and tissue damage11
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC11
Nanoparticles for generating antigen-specific T cells for immunotherapy11
The role of ILC subsets in cancer11
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond10
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation10
Reparative inflammation in multiple sclerosis10
Galectins and Host–Pathogen Interactions: The roles in viral infections10
Regulatory T cells in allergic inflammation10
The gut-brain vascular axis in neuroinflammation10
Integrating immunopeptidome analysis for the design and development of cancer vaccines10
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease10
Editorial Board10
Complement regulation in tumor immune evasion10
Polyvalent design in the cGAS-STING pathway10
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data10
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions10
Systems analysis of human innate immunity in COVID-199
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies9
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences9
Neutrophil metabolism in the cancer context9
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives9
Nanoalum adjuvanted vaccines: small details make a big difference9
Publisher’s Note: A change in leadership9
Immunity to fungi in the lung9
0.062345027923584